Arsenic trioxide induced the apoptosis of laryngeal cancer via down-regulation of survivin mRNA

Auris Nasus Larynx

Volumn 35, Issue 1, 2008, Pages 95-101

  Cheng, Baohua ^a   Yang, Xinxin ^b   Han, Zaiwen ^c   An, Liangxiang ^d   Liu, Shuwei ^a  

^a SHANDONG UNIVERSITY   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

^c WEIFANG PEOPLE'S HOSPITAL   (China)

^d Rizhao People's Hospital   (China)

Author keywords

Apoptosis; Arsenic trioxide; Hep 2 cell line; LSCC; Survivin

Indexed keywords

ACRIDINE ORANGE; ARSENIC TRIOXIDE; CASPASE 3; MESSENGER RNA; SURVIVIN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; LARYNX CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION; HUMANS; LARYNGEAL NEOPLASMS; MICROSCOPY, FLUORESCENCE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; OXIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 37749047583     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2007.07.009     Document Type: Article

References (33)

1. Russo A., Corsale S., Agnese V., Macaluso M., Cascio S., Bruno L., et al. TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma. J Cell Physiol 206 1 (2006) 181-188
2. Skandalis S.S., Theocharis A.D., Papageorgakopoulou N., Vynios D.H., and Theocharis D.A. The increased accumulation of structurally modified versican and decorin is related with the progression of laryngeal cancer. Biochimie 88 9 (2006) 1135-1143
3. Ai Z., Lu W., and Qin X. Arsenic trioxide induces gallbladder carcinoma cell apoptosis via downregulation of Bcl-2. Biochem Biophys Res Commun 348 3 (2006) 1075-1081
4. Jackel M.C., Dorudian M.A., Marx D., Brinck U., Schauer A., and Steiner W. Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression. Cancer 85 3 (1999) 591-599
5. Izawa H., Yonemitsu N., Shin T., and Sugihara H. Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia. Auris Nasus Larynx 26 3 (1999) 317-330
6. Li B., Liu X., Fan J., Qi R., Bo L., Gu J., et al. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo. J Gene Med 8 10 (2006) 1232-1242
7. Zhang T.C., Cao E.H., Li J.F., Ma W., and Qin J.F. Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide. Eur J Cancer 35 8 (1999) 1258-1263
8. Siu K.P., Chan J.Y., and Fung K.P. Effect of arsenic trioxide on human hepatocellular carcinoma HepG2 cells: inhibition of proliferation and induction of apoptosis. Life Sci 71 3 (2002) 275-285
9. Park J.W., Choi Y.J., Jang M.A., Baek S.H., Lim J.H., Passaniti T., et al. Arsenic trioxide induces G2/M growth arrest and apoptosis after caspase-3 activation and Bcl-2 phosphorylation in promonocytic U937 cells. Biochem Biophys Res Commun 286 4 (2001) 726-734
10. McNeish I.A., Lopes R., Bell S.J., McKay T.R., Fernandez M., Lockley M., et al. Survivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosis. Exp Cell Res 302 1 (2005) 69-82
11. Ferrandina G., Legge F., Martinelli E., Ranelletti F.O., Zannoni G.F., Lauriola L., et al. Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters. Br J Cancer 92 2 (2005) 271-277
12. Johnson M.E., and Howerth E.W. Survivin: a bifunctional inhibitor of apoptosis protein. Vet Pathol 41 6 (2004) 599-607
13. Pizem J., Cor A., and Gale N. Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation. Histopathology 45 2 (2004) 180-186
14. Li Q.X., Zhao J., Liu J.Y., Jia L.T., Huang H.Y., Xu Y.M., et al. Survivin stable knockdown by siRNA inhibits tumor cell growth and angiogenesis in breast and cervical cancers. Cancer Biol Ther 5 7 (2006) 860-866
15. Ning S., Fuessel S., Kotzsch M., Kraemer K., Kappler M., Schmidt U., et al. SiRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth. Int J Oncol 25 4 (2004) 1065-1071
16. Uchida H., Tanaka T., Sasaki K., Kato K., Dehari H., Ito Y., et al. Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo. Mol Ther 10 1 (2004) 162-171
17. Nakao K., Hamasaki K., Ichikawa T., Arima K., Eguchi K., and Ishii N. Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis. Oncol Rep 16 2 (2006) 389-392
18. Fuessel S., Herrmann J., Ning S., Kotzsch M., Kraemer K., Schmidt U., et al. Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA. Cancer Lett 232 2 (2006) 243-254
19. Kami K., Doi R., Koizumi M., Toyoda E., Mori T., Ito D., et al. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells. Surgery 138 2 (2005) 299-305
20. Cheng Y., Chang L.W., and Tsou. Mitogen-activated protein kinases mediate arsenic-induced down-regulation of survivin in human lung adenocarcinoma cells. Arch Toxicol 80 6 (2006) 310-318
21. Jia R.R., Gou Y.L., Ho L.S., Ng C.P., Tan N.H., and Chan H.C. Anti-apoptotic activity of Bak Foong Pills and its ingredients on 6-hydroxydopamine-induced neurotoxicity in PC12 cells. Cell Biol Int 29 10 (2005) 835-842
22. Baumgartner M., Sturlan S., Roth E., Wessner B., and Bachleitner-Hofmann T. Enhancement of arsenic trioxide-mediated apoptosis using docosahexaenoic acid in arsenic trioxide-resistant solid tumor cells. Int J Cancer 112 4 (2004) 707-712
23. 3). FEBS Lett 519 1-3 (2002) 195-200
24. Sohn D.M., Kim S.Y., Baek M.J., Lim C.W., Lee M.H., Cho M.S., et al. Expression of survivin and clinical correlation in patients with breast cancer. Biomed Pharmacother 60 6 (2006) 289-292
25. Zhen H.N., Zhang X., Hu P.Z., Yang T.T., Fei Z., Zhang J.N., et al. Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas. Cancer 104 12 (2005) 2775-2783
26. Sah N.K., Khan Z., Khan G.J., and Bisen P.S. Structural, functional and therapeutic biology of survivin. Cancer Lett 244 2 (2006) 164-171
27. Ciesielski M.J., Apfel L., Barone T.A., Castro C.A., Weiss T.C., and Fenstermaker R.A. Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas. Cancer Immunol Immunother 55 12 (2006) 1491-1503
28. Pratt M.A., Niu M.Y., and Renart L.I. Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells. Apoptosis 11 4 (2006) 589-605
29. Tarnawski A., Pai R., Chiou S.K., Chai J., and Chu E.C. Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B. Biochem Biophys Res Commun 334 1 (2005) 207-212
30. Yang J., Li H., Chen Y.Y., Wang X.J., Shi G.Y., Hu Q.S., et al. Anthraquinones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo via reactive oxygen species-mediated dual regulation of apoptosis. Free Radic Biol Med 37 12 (2004) 2027-2041
31. 2): in vivo studies in Wistar rats as well as in vitro studies in human cervical cancer cells. J Pharmacol Exp Ther 311 3 (2004) 22-33
32. Hyun Park W., Hee Cho Y., Won Jung C., Oh Park J., Kim K., Hyuck Im Y., et al. Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis. Biochem Biophys Res Commun 300 1 (2003) 230-235
33. Kawamura K., Sato N., Fukuda J., Kodama H., Kumagai J., Tanikawa H., et al. Survivin acts as an antiapoptotic factor during the development of mouse preimplantation embryos. Dev Biol 256 2 (2003) 331-341